期刊文献+

具有内皮细胞选择性的细胞膜仿生支架材料的研究 被引量:5

CONSTRUCTION OF BIOMIMETIC POLYMER SURFACE FOR ENDOTHELIAL CELL SELECTIVITY
原文传递
导出
摘要 利用AIBN引发自由基反应,由单体2-(甲基丙烯酰氧基)乙基-2-(三甲基氨基)乙基磷酸酯(MPC)、甲基丙烯酸十八酯(SMA)、对硝基苯氧羰基聚乙二醇甲基丙烯酸酯(MEONP)合成了一种新型类细胞膜仿生涂层材料.MPC可以阻抗非特异性吸附;MEONP可以结合抗体或多肽促进特异性识别.通过表面固定的方法引入多肽序列Arg-Glu-Asp-Val(REDV),使涂层具有内皮细胞选择性.核磁、紫外吸收、红外光谱表征证实聚合物的组成以及REDV多肽在表面的固定;并通过血浆复钙化实验表征涂层的血液相容性.细胞黏附与增殖实验反映REDV多肽构建的涂层表面具备良好的特异性识别并结合内皮细胞的能力. This paper aimed to describe a bioactive polymer biointerface for endothelial cells specifically recognition.In particular,biomembrane mimetic polymers with a phospholipid group were designed.A phospholipid polymer-poly[2-methacryloyloxyethyl phosphorylcholine(MPC)-co-n-stearyl methacrylate(SMA)-co-p-nitrophenyloxycarbonyl poly(ethylene glycol) methacrylate(MEONP)](PMSN) was synthesized using AIBN as an initiator and coated on substrate(PET) by solvent evaporation.MPC unit could reduce nonspecific adsorption such as platelet,protein and cells.MEONP unit contains active ester groups on the side chains for immobilization of antibody or peptide sch as REDV.The peptide sequence Arg-Glu-Asp-Val(REDV) was known to bind preferentially to endothelial cells.As a result,MEONP units could conjugate REDV and enhance the specific endothelial cells adsorption.HNMR,UV and FTIR spectrum were used to characterize the composition of polymer and immobilization of REDV peptide plasma recaleification time(PRT) was detected to show the hemocompatibility of polymer coating.Cell adhesion and proliferation experiments showed excellent specific recognition of endothelia cells on biomimetic coatings.Many endothelial cells were observed and the number of endothelial cells adhering to the PMSN polymer surfaces increased but cell adhesion was markedly reduced on poly(MPC-co-SMA)(PMS).For smooth muscle cells(SMC),many adherent cells were observed and well spread on PET but little on PMS and PMSN by the reason of nonspecific adhesion of MPC for smooth muscle cells.In conclusion,MEONP units and MPC units of PMSN are important for supporting ECs and for reducing SMCs.The PMSN-coated surface was suitable for biorecognition and preservation of cell function.The biomembrane mimetic phospholipid polymer produced an excellent prospect in cardiovascular stent coating.
出处 《高分子学报》 SCIE CAS CSCD 北大核心 2010年第12期1474-1478,共5页 Acta Polymerica Sinica
基金 国家自然科学基金(基金号50830106) 浙江省自然科学基金(基金号Y4080250) 教育部博士点基金(基金号20070335024) 超分子结构与材料国家重点实验室(吉林大学)开放基金(基金号SKLSSM200911)资助项目
关键词 内皮选择性 支架涂层 磷酸胆碱 多肽 Endothelial cell selectivity Stent coating MPC REDV peptide
  • 相关文献

参考文献16

  • 1贾兰,徐建平,计剑,沈家骢.细胞膜仿生修饰树枝状聚酰胺-胺的研究[J].高分子学报,2008,18(11):1108-1112. 被引量:9
  • 2徐方明,徐建平,计剑,沈家骢.一种仿细胞膜聚合物用于碳纳米管表面改性[J].高分子学报,2008,18(10):1006-1009. 被引量:3
  • 3Lüscher T F,Steffel J,Eberli F R,Joner M,Nakazawa G,Tanner F C,Virmani R. Circulation . 2007
  • 4Deamon J,Wenaweser P,Tsuchida K,Abrecht L,Vaina S,Morger C,Kukregja N,Jüni P,Sianos G,Hellige G,Domburg R T,Hess O M,Boersma E,Meier B,Windecker S,Serruys P. The Lancet . 2007
  • 5Cho S W,,Lim J E,Chu H S,Hyun H J,Choi C Y,Hwang K C,Yoo K J,Kim D I,Kim B S. Journal of Biomedical Materials Research . 2006
  • 6Li G Z,Cheng G,Xue H,Chen S F,Zhang F B,Jiang S Y. Biomaterials . 2008
  • 7Chen Y W,Chen N C,Qiu Z,Wang L J,Wan C X,Luo X L,Li S M. Macromol Biosci . 2009
  • 8Su Y L,Li C,Zhao W,Shi Q,Wang H J,Jiang Z Y,Zhu S P. Journal of Membrane Science . 2008
  • 9Han Y L,Cui J F,Tao J,Guo L,Guo P,Sun M Y,Kang J,Zhang X L,Yan C H,Li S H. Experimental Cell Research . 2009
  • 10Avci-Adali M,Paul A,Ziemer G,et al. Biomaterials . 2008

二级参考文献26

共引文献10

同被引文献58

  • 1余贯华,计剑,王东安,沈家骢.RGD改性聚醚氨酯及其内皮细胞相容性的研究[J].高等学校化学学报,2005,26(6):1156-1161. 被引量:6
  • 2Goto K., Shiode N, Shirota K., Fukuda Y., Kitamura F., Tominaga K., Kato Y., Miura H., Inoue K., Nobuyoshi M.. Circulation Journal[J]..2009, 73(10):1969-1971.
  • 3Lookstein R. A., Talenfeld AD., Raju R., Vorchheimer D. A., Olin J. W., Marin M. L.. Vascular Medicine[J]..2009, 14(4):361-364.
  • 4Nakazawa G., Finn A. V., Vorpahl M., Ladich E., Kutys R., Balazs I., Kolodgie F. D., Virmani R.. Journal of the American College of Cardiology[J], 2009, 54(21): 1924-1931.
  • 5Kukreja N., Onuma Y., Daemen J., Serruys P. W.. Pharmacological Research[J], 2008, 57(3): 171-180.
  • 6Carlsson J., von Wangenheim B., Linder R., Anwari T. M., Qvist J., Petersson I., Magounakis T., Lagerqvist B.. Clin. Res. Cardiol.[J], 2007, 96(2): 86-93.
  • 7Lin Q. K., Din X., Qiu F. Y., Song X. X., Fu G. S., Ji J.. Biomaterials[J], 2010, 31(14): 4017-4025.
  • 8Park J., Kurosawa S, Watanabe J., Ishihara K.. Anal. Chem.[J]..2004, 76(9):2649-2655.
  • 9Plouffe B. D., Njoka DN., Harris J., Liao J. H., Horick N. K., Radisic M., Murthy S. K.. Langmuir[J]..2007, 23(9):5050-5055.
  • 10Dangas G D;Claessen B E;Caixeta A;Sanidas E A Mintz G S Mehran R.查看详情[J],Journal of the American College of Cardiology20101897-1907.

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部